Loading page content...
Newborn Screening, or Neonatal Screening, is a critical diagnostic process performed within the first few days of a baby’s life to detect inborn errors of metabolism, endocrine disorders, genetic conditions, and other serious health abnormalities that may not show visible symptoms at birth. Early identification enables prompt medical intervention, helping prevent severe physical, cognitive, and neurological complications while improving long-term health outcomes. We offer a comprehensive portfolio of Newborn Screening solutions, including modular and fully automated platforms, manual and automated equipment, and advanced reagent kits designed for reliable and high-throughput screening workflows.
Provide high-performance Newborn Screening kits and reagents developed for precise and reliable neonatal disorder detection. Designed for compatibility with modern screening systems, these reagents ensure analytical consistency, enhanced assay sensitivity, and dependable screening outcomes for early disease identification.
Newborn Screening (NBS) instruments are designed for accurate, high-throughput detection of metabolic, genetic, and endocrine disorders in newborns. The portfolio includes modular, semi-automated, and fully automated platforms engineered to support reliable screening workflows, faster turnaround time, and enhanced laboratory efficiency.